Zahra Masoud

COVID-19 as a cause of increased risk of stroke was assessed by research authors, who compiled discharge data from electronic medical records from 6 stroke facilities in New York.

Study authors assessed the association between mortality and age, history of cardiac surgery, and other risk factors in patients undergoing surgery for infective endocarditis.

Researchers conducted a prospective study to analyze the relationship between continued angiotensin-converting enzyme inhibitor (ACEi) or angiotensin II receptor blocker (ARB) use in the hospital and better clinical outcomes (ICU admission, morbidity, mortality).

Trends in infective endocarditis microbiology are of clinical concern and require further study and additional data.

Algorithms may help predict cardiovascular disease risk in people living with HIV.

Higher proprotein convertase subtilisin/kexin 9 levels are associated with marijuana consumption and low CD4 values in people living with HIV.

High-risk human papillomavirus infection may be associated with the risk for cardiovascular disease in Korean women.

The current available influenza vaccine may have prevented substantial cases of influenza-associated adverse outcomes.

Cefiderocol, a novel siderophore cephalosporin, may be successful in patients with persistently bacteremic nosocomial native aortic valve endocarditis.

The 2007 AHA recommendation for antibiotic prophylaxis for only patients at high risk for infective endocarditis may result in increased incidence of the infection.